Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Fluoroaniracetam: Initial Biodistribution and Characterization of a new Brain Imaging Agent

Dustin Osborne, Alan Stuckey, Steve Kennel, David Blevins and Murthy Akula
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1103;
Dustin Osborne
1Graduate School of Medicine, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan Stuckey
1Graduate School of Medicine, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Kennel
1Graduate School of Medicine, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Blevins
1Graduate School of Medicine, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murthy Akula
1Graduate School of Medicine, University of Tennessee, Knoxville, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1103

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Dustin Osborne1,
  2. Alan Stuckey1,
  3. Steve Kennel1,
  4. David Blevins1 and
  5. Murthy Akula1
  1. 1Graduate School of Medicine, University of Tennessee, Knoxville, TN

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to April 2025

AbstractFullPdf
May 2015400
Jun 2015900
Jul 20151000
Aug 2015400
Sep 2015900
Oct 2015300
Dec 2015600
Jan 2016500
Feb 2016500
Mar 2016300
May 2016200
Jun 2016100
Jul 2016700
Aug 2016100
Sep 2016300
Oct 2016100
Nov 2016100
Dec 2016200
Jan 2017400
Feb 2017100
Apr 2017300
May 2017100
Jun 2017200
Jul 20171100
Aug 2017400
Oct 2017100
Nov 2017100
Jan 2018300
Feb 2018300
Mar 2018100
Apr 2018100
Jul 2018100
Sep 2018300
Oct 2018100
Nov 2018100
Mar 2019100
Apr 20192300
Jul 2019300
Sep 2019100
Dec 2019700
Feb 2020100
Mar 2020100
Jul 2020200
Aug 2020100
Dec 2020100
Feb 2021500
Mar 2021300
Apr 2021600
May 20211300
Jun 20211300
Jul 20216200
Aug 202114500
Sep 2021200
Oct 2021200
Nov 20213200
Dec 20211100
Jan 2022100
Feb 2022500
Mar 2022200
Apr 2022800
May 2022200
Jun 2022400
Jul 2022100
Aug 2022100
Sep 2022100
Nov 2022300
Dec 2022100
Mar 2023500
Apr 2023100
May 2023100
Jun 2023200
Jul 2023300
Aug 2023200
Sep 2023100
Oct 2023100
Nov 2023200
Dec 2023200
Jan 2024400
Feb 2024100
Mar 2024200
Apr 2024200
May 2024200
Jun 2024100
Jul 2024100
Aug 20241600
Sep 20241400
Nov 2024300
Dec 2024400
Jan 2025200
Mar 2025500
Apr 2025200
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Fluoroaniracetam: Initial Biodistribution and Characterization of a new Brain Imaging Agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Fluoroaniracetam: Initial Biodistribution and Characterization of a new Brain Imaging Agent
Dustin Osborne, Alan Stuckey, Steve Kennel, David Blevins, Murthy Akula
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1103;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Fluoroaniracetam: Initial Biodistribution and Characterization of a new Brain Imaging Agent
Dustin Osborne, Alan Stuckey, Steve Kennel, David Blevins, Murthy Akula
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1103;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • Relationships between tau, atrophy, regional brain activity and connectivity in Alzheimer's disease: a PET/MRI multimodal study
  • Gray matter structural networks related to 18F-THK5351 retention in cognitively normal older adults and early Alzheimer’s disease patients
  • Assessment of α4β2 nicotinic acetylcholine receptor (nAChR) availability and neuronal response to rewarding food-cues in human obesity using simultaneous PET-MRI
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

Special MTA: Preclinical Probes for Neuroimaging Posters

  • Preclinical evaluation of novel PET-tracers for tau imaging
  • Development of Novel PET Imaging Agents for Vesicular Monoamine Transporter Type 2
  • Development of 2-[18F]trifluoromethyl-L-tryptophan (2-[18F]CF3-L-Trp) for serotonergic system imaging
Show more Special MTA: Preclinical Probes for Neuroimaging Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire